Condition
Postpericardiotomy Syndrome
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
P 2 (1)
P 3 (3)
Trial Status
Completed2
Recruiting1
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05726019Phase 2Completed
Colchicine in Patients Undergoing Coronary Artery Bypass Grafting After Acute Coronary Syndrome
NCT06768528Recruiting
Association Between GalectiN-3 and POSt-operative AtrIal Fibrillation After Coronary Artery BypaSs Graft
NCT02177266Phase 3Terminated
Colchicine to Prevent Post-Pericardiotomy Syndrome and Atrial Fibrillation
NCT01552187Phase 3Unknown
COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial)
NCT00128427Phase 3CompletedPrimary
Study of Colchicine to Prevent the Postpericardiotomy Syndrome
Showing all 5 trials